Tatva Chintan Pharma Chem Q4FY22 consolidated PAT drops at Rs. 17.50 Cr
Chemical

Tatva Chintan Pharma Chem Q4FY22 consolidated PAT drops at Rs. 17.50 Cr

The company has reported total income of Rs. 98.88 crores during the quarter ended March 31, 2022

  • By ICN Bureau | April 27, 2022

Tatva Chintan Pharma Chem has reported total income of Rs. 98.88 crores during the quarter ended March 31, 2022 as compared to Rs. 109.23 crores during the quarter ended December 31, 2021. The company reported total income of Rs.111.25 crores during the period ended March 31, 2021.

Tatva Chintan Pharma Chem has posted net profit of Rs. 17.50 crores for the quarter ended March 31, 2022 as against net profit of Rs. 22.80 crores for the quarter ended December 31, 2021. It posted net profit of Rs.21.11 crores for the period ended March 31, 2021.

Tatva Chintan has reported total income of Rs.442.54 crores during the Financial Year ended March 31, 2022 as compared to Rs.305.55 crores during the Financial Year ended March 31, 2021. It posted net profit of Rs.95.87 crores for the Financial Year ended March 31, 2022 as against net profit of Rs.52.26 crores for the Financial Year ended March 31, 2021.

Register Now to Attend Chem Connect 2025 on August 21th 2025, Novotel Mumbai International Airport

Upcoming Conferences

Chem Connect 2025

August 21, 2025

Agrochem Summit 2025

November 19, 2025

Other Related stories

Startups

Petrochemical

Energy

Digitization